Medtronic plc.
Every calculator, already run for MDT
Open the full toolkit →You have the numbers on MDT. Get the argument.
A written report on which of these readings actually decide the outcome for Medtronic plc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
29 analysts covering MDTOwnership & short interest
About Medtronic plc.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent graft…
MDT — frequently asked
Is MDT a buy right now?
Wall Street's consensus rating on Medtronic plc. is Buy across 29 analysts, with a mean price target of $98.44 (+15% vs. the current $85.62). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is MDT overvalued?
MDT trades at 23.1x trailing earnings. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is MDT's next earnings date?
Medtronic plc. is next scheduled to report earnings around Sep 1, 2026. A full MDT research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
Compare Medtronic plc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Medtronic plc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full MDT research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Medtronic plc., in minutes. 3 free reports included with every account — no credit card required.